Refractory T Acute Lymphoblastic Leukemia
7 clinical trials · Condition
◉ Watch Refractory T Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL) (NCT04315324) | SWOG Cancer Research Network | 2021-02-08 |
| Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105) | City of Hope Medical Center | 2020-11-18 |
| Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia (NCT03808610) | M.D. Anderson Cancer Center | 2019-04-03 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644) | ECOG-ACRIN Cancer Research Group | 2018-08-13 |
Track Refractory T Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.